ImmunityBio
IBRX
#3744
Rank
HK$18.77 B
Marketcap
HK$22.00
Share price
-4.71%
Change (1 day)
-50.00%
Change (1 year)

ImmunityBio (IBRX) - Cash on Hand

Cash on Hand as of December 2024 : HK$1.16 Billion

According to ImmunityBio's latest financial reports the company has HK$1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ImmunityBio - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$1.16 B-44.11%
2023-12-31HK$2.08 B148.5%
2022-12-31HK$0.83 B-66.13%
2021-12-31HK$2.47 B232.05%
2020-12-31HK$0.74 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$1.98 B 70.86%๐Ÿ‡บ๐Ÿ‡ธ USA